β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neurochemistry

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2004.02895.xPMID 15659232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Using and understanding medical statistics

  2007cited by this paper
• Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1

  2004cited by this paper
• Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.

  2004cited by this paper
• BACE1 Suppression by RNA Interference in Primary Cortical Neurons*

  2004cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003cited by this paper
• Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes.

  2003cited by this paper
• JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease

  2003cited by this paper
• Oxidized neprilysin in aging and Alzheimer's disease brains.

  2003cited by this paper
• Increased Apoptotic Cell Death in Sporadic and Genetic Alzheimer's Disease

  2003cited by this paper
• Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways

  2003cited by this paper
• 4-hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions.

  2003cited by this paper
• Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress.

  2003cited by this paper
• Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis.

  2003cited by this paper
• Oxidative stress increases expression and activity of BACE in NT2 neurons.

  2002cited by this paper
• Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.

  2002cited by this paper
• Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

  2002cited by this paper
• Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases.

  2002cited by this paper
• Platelet‐activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation

  2002cited by this paper
• Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

  2002cited by this paper
• Reactive Oxygen Species Regulate Heat-Shock Protein 70 via the JAK/STAT Pathway

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

  2001cited by this paper
• Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

  2001cited by this paper
• Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

  2001cited by this paper
• Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

  2001cited by this paper
• How important is oxidative damage? Lessons from Alzheimer's disease.

  2000cited by this paper
• Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

  2000cited by this paper
• JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system.

  2000cited by this paper
• Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of Pharmacotherapy

  2000cited by this paper
• Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

  2000cited by this paper
• Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

  2000cited by this paper
• E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3*

  2000cited by this paper
• In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification

  2000cited by this paper
• Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells.

  2000cited by this paper
• Oxidative Stress Induces Increase in Intracellular Amyloid β-Protein Production and Selective Activation of βI and βII PKCs in NT2 Cells

  2000cited by this paper
• Oxidative damage in Alzheimer's disease: the metabolic dimension

  2000cited by this paper
• Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein

  2000cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

  1999cited by this paper
• Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Identification of a novel aspartic protease (Asp 2) as beta-secretase.

  1999cited by this paper
• β-Amyloid Fibrils Activate Parallel Mitogen-Activated Protein Kinase Pathways in Microglia and THP1 Monocytes

  1998cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.

  1998cited by this paper
• Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease

  1998cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• Using and understanding medical statistics. 2nd edn.: D.E. Matthews and V.T. Farewell, Karger, Basel, 1988

  1989cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

  year unknowncited by this paper

• Quinic acid and its derivatives protect against phytohaemagglutinin-induced Alzheimer's-like neurotoxicity in SH-SY5Y cells by down-regulating p38 MAPK signaling pathway.

  2025cites this paper
• Sea Squirt-Derived Peptide WLP Mitigates OKA-Induced Alzheimer’s Disease-like Phenotypes in Human Cerebral Organoid

  2025cites this paper
• Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer’s Disease with Therapeutic Implications

  2025cites this paper
• Neuroprotective and Nootropic Effects of a Standardised Siddha Polyherbal Formulation, Bhiramiyadhi Bhavanai Choornam, Against β-Amyloid-Induced Neurodegeneration.

  2025cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

  2024influential citation
• Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer’s Disease

  2024cites this paper
• Mechanistic Approach to Immunity and Immunotherapy of Alzheimer's Disease: A Review.

  2024cites this paper
• Mechanisms of mitophagy and oxidative stress in cerebral ischemia–reperfusion, vascular dementia, and Alzheimer’s disease

  2024cites this paper
• Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review

  2024cites this paper
• Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease.

  2024cites this paper
• From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies

  2024cites this paper
• Neuronal glutathione depletion elevates the Aβ42/Aβ40 ratio and tau aggregation in Alzheimer's disease mice

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer’s Disease and Other Neurodegenerative Diseases

  2024cites this paper
• Effects of DHA (omega-3 fatty acid) and estradiol on amyloid β-peptide regulation in the brain.

  2023cites this paper
• An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease

  2023cites this paper
• Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease

  2023cites this paper
• Mediterranean Shrub Species as a Source of Biomolecules against Neurodegenerative Diseases

  2023cites this paper
• Intraneuronal accumulation of amyloid-β peptides as the pathomechanism linking autism and its co-morbidities: epilepsy and self-injurious behavior — the hypothesis

  2023cites this paper
• Sesamol: A Phenolic Compound of Health Benefits and Therapeutic Promise in Neurodegenerative Diseases.

  2023cites this paper
• Brain-derived neurotrophic factor interplay with oxidative stress: neuropathology approach in potential biomarker of Alzheimer’s disease

  2023cites this paper
• The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• The Yin and Yang Effect of the Apelinergic System in Oxidative Stress

  2023cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2023cites this paper
• Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease

  2023cites this paper
• Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders.

  2023cites this paper
• Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases: Expanding the Therapeutic Approaches by Plant-Derived Natural Products

  2023cites this paper
• Soy protein increases cognitive level in mice by modifying hippocampal nerve growth, oxidative stress, and intestinal microbiota.

  2022cites this paper
• Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy

  2022cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• DNA Damage Increases Secreted Aβ40 and Aβ42 in Neuronal Progenitor Cells: Relevance to Alzheimer’s Disease

  2022cites this paper
• Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer’s Disease: A Retrospective Inception Cohort Study

  2022cites this paper
• Mechanistic Insights into the Neuroprotective Potential of Sacred Ficus Trees

  2022cites this paper
• Dietary vitamin B6 restriction aggravates neurodegeneration in mice fed a high-fat diet.

  2022cites this paper
• Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease

  2022cites this paper
• Microalgae as a potential therapeutic drug candidate for neurodegenerative diseases.

  2022cites this paper
• Cannabidiol for neurodegenerative disorders: A comprehensive review

  2022cites this paper
• Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2022cites this paper
• Quercetin Increases Mitochondrial Biogenesis and Reduces Free Radicals in Neuronal SH-SY5Y Cells

  2022cites this paper
• Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease

  2021cites this paper
• Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations.

  2021cites this paper
• Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?

  2021cites this paper
• Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer’s disease? A hypothesis

  2021influential citation
• Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

  2021cites this paper
• Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

  2021cites this paper
• Sex differences in Alzheimer's disease: metabolic reprogramming and therapeutic intervention.

  2021cites this paper
• Environmental Toxins and Alzheimer's Disease Progression.

  2020cites this paper
• Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases

  2020cites this paper
• Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice

  2020cites this paper
• Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress

  2020influential citation
• The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence

  2020cites this paper
• Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease

  2020cites this paper
• Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database

  2020cites this paper
• Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein

  2020cites this paper
• Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

  2020cites this paper
• Combined Structure and Ligand-Based Design of Selective Acetylcholinesterase Inhibitors

  2020cites this paper
• Identification of 4-hydroxynonenal-modified proteins in human osteoarthritic chondrocytes.

  2020cites this paper
• Neuroprotective expression of turmeric and curcumin

  2020cites this paper
• Manganese increases Aβ and Tau protein levels through proteasome 20S and heat shock proteins 90 and 70 alteration, leading to SN56 cholinergic cell death following single and repeated treatment.

  2020cites this paper
• Mechanism and biomarkers for neurodegenerative diseases: A systematic review

  2020cites this paper
• Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases

  2020cites this paper
• Neuroprotective Effects of Higenamine Against the Alzheimer’s Disease Via Amelioration of Cognitive Impairment, Aβ Burden, Apoptosis and Regulation of Akt/GSK3β Signaling Pathway

  2020cites this paper
• PGPM_A_269726 487..502

  2020cites this paper
• Determining the Fate of Neurons in SCA3: ATX3, a Rising Decision Maker in Response to DNA Stresses and Beyond

  2020cites this paper
• Natural Antioxidant Anthocyanins—A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration

  2019cites this paper
• MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells

  2019cites this paper
• Icariin and Its Metabolites as Potential Protective Phytochemicals Against Alzheimer’s Disease

  2019cites this paper
• The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.

  2019cites this paper
• Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer’s disease

  2019cites this paper
• Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease

  2019influential citation
• Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.

  2019cites this paper
• Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.

  2019cites this paper
• Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic mice.

  2019cites this paper
• Primary hippocampal estrogenic dysfunction induces synaptic proteins alteration and neuronal cell death after single and repeated paraquat exposure.

  2019cites this paper
• The role of mitochondrial defects and oxidative stress in Alzheimer’s disease

  2019influential citation
• Beta-Amyloid Increases the Expression Levels of Tid1 Responsible for Neuronal Cell Death and Amyloid Beta Production

  2019cites this paper
• PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions

  2019cites this paper
• Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.

  2019cites this paper
• Role of endolysosomes and inter-organellar signaling in brain disease.

  2019cites this paper
• Inhibition of MAPKs Signaling Pathways Prevents Acrolein-Induced Neurotoxicity in HT22 Mouse Hippocampal Cells.

  2019cites this paper
• Upregulation of Cisd2 attenuates Alzheimer's‐related neuronal loss in mice

  2019cites this paper
• CSF sAPPα and sAPPβ levels in Alzheimer’s Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis

  2019cites this paper
• Effects of Docosahexaenoic Acid and Its Peroxidation Product on Amyloid-β Peptide-Stimulated Microglia

  2019cites this paper
• Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

  2018cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2018cites this paper
• Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

  2018cites this paper
• Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice

  2018cites this paper
• Interventions for age-related diseases

  2018cites this paper
• BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice

  2018cites this paper
• Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide

  2018cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2018cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2018cites this paper
• Apelin, a promising target for Alzheimer disease prevention and treatment.

  2018cites this paper
• Accelerated aging and aging process in the brain

  2018cites this paper
• A Unified View of Assessing the Pro‐oxidant versus Antioxidant Nature of Amyloid Beta Conformers

  2018cites this paper
• Cadmium induced ROS alters M1 and M3 receptors, leading to SN56 cholinergic neuronal loss, through AChE variants disruption.

  2018cites this paper
• Nitrative Stress and Tau Accumulation in Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) in the Kii Peninsula, Japan

  2018cites this paper
• Mitochondrial dysfunction and the role of Mitophagy in Alzheimer ’ s Disease 1 MedDocs eBooks

  2018cites this paper